Skip to content
20-F

Annual Report (Foreign)

Jin Medical International Ltd. ZJYL

0001213900-25-006519

← back to feed
Filed
Jan 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Debt FY 2024 · Aug 20, 2024 ¥10M
Short Term Debt FY 2024 · Aug 20, 2024 $1.43M
Short Term Debt FY 2024 · Aug 12, 2024 ¥10M
Short Term Debt FY 2024 · Aug 12, 2024 $1.43M
Short Term Debt FY 2024 · Jul 31, 2024 ¥10M
Short Term Debt FY 2024 · Jul 31, 2024 $1.43M
Short Term Debt FY 2024 · Sep 30, 2023 $4.11M
Short Term Investments FY 2024 · Sep 30, 2023 $9.77M
Stockholders Equity FY 2024 · Sep 30, 2023 $23.98M
Current Liabilities FY 2024 · Sep 30, 2023 $8.92M
Total Liabilities FY 2024 · Sep 30, 2023 $8.92M
Current Assets FY 2024 · Sep 30, 2023 $31.12M
Total Assets FY 2024 · Sep 30, 2023 $32.9M
Shares Diluted FY 2024 · Sep 30, 2022 135M sh
Capex FY 2024 · Sep 30, 2022 $40.17K
Operating Cash Flow FY 2024 · Sep 30, 2022 $1.58M
Eps Diluted FY 2024 · Sep 30, 2022 $0.02
Eps Basic FY 2024 · Sep 30, 2022 $0.02
Sga Expense FY 2024 · Sep 30, 2022 $1.77M
Rd Expense FY 2024 · Sep 30, 2022 $1.89M
Net Income FY 2024 · Sep 30, 2022 $2.71M
Operating Income FY 2024 · Sep 30, 2022 $2.13M
Gross Profit FY 2024 · Sep 30, 2022 $6.2M
Cost Of Revenue FY 2024 · Sep 30, 2022 $12.99M
Revenue FY 2024 · Sep 30, 2022 $19.19M